Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

685
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
685

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Culturally and regionally relevant physical activity for public health promotion in a global context: nature of the evidence and definition development from a narrative review.

BMJ public health·2026
Same author

Health literacy and the Pacific: A scoping literature review of journal articles.

Public health·2025
Same author

Exploring the Impact of Social Connection Dimensions on Cognitive Impairment in Older Adults: Observational Cohort Study.

Inquiry : a journal of medical care organization, provision and financing·2025
Same author

Prediction of mammographic breast density based on clinical breast ultrasound images using deep learning: a retrospective analysis.

Lancet regional health. Americas·2025
Same author

Filipinos and Parkinson's disease: A scoping review of the literature.

Parkinsonism & related disorders·2025
Same author

The Impact of a Commensality Intervention on Physician Burnout.

Hawai'i journal of health & social welfare·2024

Related Experiment Video

Updated: Sep 9, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.2K

Exploring Diabetes Clinical Trial Participation: A Diverse Group Interview Study.

Deborah A Taira1,2, Kauilaonālani Tengan3, Julia Takata3

  • 1The Queen's Medical Center, Honolulu, HI, USA. dtjuarez@hawaii.edu.

Therapeutic Innovation & Regulatory Science
|August 30, 2025
PubMed
Summary
This summary is machine-generated.

To improve clinical trial diversity, tailor recruitment by highlighting community benefits and using trusted local doctors. Communication preferences vary by ethnicity, with many patients willing to join if asked.

Keywords:
Asian continental ancestry groupCommunicationDiabetes mellitus, type 2Oceanic ancestry groupPatient participation

More Related Videos

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.1K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

370

Related Experiment Videos

Last Updated: Sep 9, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.2K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.1K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

370

Area of Science:

  • Health disparities
  • Clinical trial recruitment
  • Health equity

Background:

  • Native Hawaiian (NH), Pacific Islander (PI), and Filipino individuals have high type 2 diabetes rates but are underrepresented in clinical trials.
  • Ensuring diverse participation in clinical trials is crucial for treatment safety and efficacy across all populations.
  • Understanding motivations and barriers for underrepresented groups is key to improving trial inclusivity.

Purpose of the Study:

  • To explore motivations, barriers, and communication preferences for clinical trial participation.
  • To focus on diverse hospitalized patients, especially underrepresented racial/ethnic groups.
  • To inform strategies for equitable clinical trial enrollment.

Main Methods:

  • In-person, semi-structured interviews with 56 hospitalized patients in Hawai'i.
  • Participants ranked reasons for trial participation and answered open-ended questions.
  • Quantitative data were summarized descriptively; qualitative data underwent Rapid Qualitative Analysis by race/ethnicity.

Main Results:

  • 84% of participants were willing to join a trial, yet most had never been invited.
  • Motivations varied: NH prioritized community/treatment access, PI focused on doctor/science, Filipino on treatments/science, White participants on incentives/community.
  • Barriers included medication risk concerns, lack of understanding, and mistrust, particularly in PI and Filipino groups. Family benefit was a key motivator for NH and PI.
  • Preferred communication: physician referrals, text messages, and physical mail across groups.

Conclusions:

  • Culturally tailored recruitment emphasizing family and community benefits is essential.
  • Involving trusted local healthcare providers can enhance participation.
  • Utilizing culturally relevant communication strategies may improve clinical trial enrollment among underrepresented populations with type 2 diabetes.